TipRanks
Nuvectis Pharma (NVCT)
NASDAQ:NVCT
US Market
NVCT
Nuvectis Pharma
RESEARCH TOOLSreports
Want to see NVCT full AI Analyst Report?

Nuvectis Pharma (NVCT) Stock News & Sentiment

140 Followers
Joseph Pantginis Lifts Nuvectis Pharma Price Target to $39 on Strong NXP200 Glioma Data, Maintains Buy Rating
Premium
Ratings
Joseph Pantginis Lifts Nuvectis Pharma Price Target to $39 on Strong NXP200 Glioma Data, Maintains Buy Rating
5d ago
NVCT
Nuvectis Reports Complete Brain Tumor Responses as Big Pharma Pays Billions for Cancer Drugs (NASDAQ: NVCT)
Premium
TipRanks Newswire
Nuvectis Reports Complete Brain Tumor Responses as Big Pharma Pays Billions for Cancer Drugs (NASDAQ: NVCT)
5d ago
MRK
PFE
Nuvectis Oncology Reaffirmed at Buy as Analyst Cites Differentiated BRAF Pipeline and Maintains $30 Price Target
Premium
Ratings
Nuvectis Oncology Reaffirmed at Buy as Analyst Cites Differentiated BRAF Pipeline and Maintains $30 Price Target
1M ago
NVCT
Nuvectis’ In-Licensed Cancer Drug Earned Breakthrough Designation in China, and It’s Not Even Their Lead Asset
Premium
TipRanks Newswire
Nuvectis’ In-Licensed Cancer Drug Earned Breakthrough Designation in China, and It’s Not Even Their Lead Asset
1M ago
AZN
NVS
Nuvectis: Buy Rating Reaffirmed as NXP Pipeline Progress and Regulatory Momentum Support Unchanged $39 Price Target
Premium
Ratings
Nuvectis: Buy Rating Reaffirmed as NXP Pipeline Progress and Regulatory Momentum Support Unchanged $39 Price Target
1M ago
NVCT
Some of the Top Biotech Funds Just Bought Into This Under-the-Radar Biotech (NASDAQ: NVCT)
Premium
TipRanks Newswire
Some of the Top Biotech Funds Just Bought Into This Under-the-Radar Biotech (NASDAQ: NVCT)
2M ago
AZN
NVCT
Nuvectis Pharma Launches New $200 Million ATM Program
Premium
Company Announcements
Nuvectis Pharma Launches New $200 Million ATM Program
2M ago
8K
NVCT
More NVCT News >

NVCT News on the Web

Nuvectis Pharma files $200M mixed securities shelf
TipRanks News
Neutral
Nuvectis Pharma Launches New $200 Million ATM Program
TipRanks News
Neutral
Nuvectis Pharma’s Heavy Reliance on Haisco Poses Major Operational and Geopolitical Risks
TipRanks News
Bearish
The Billion-Dollar Pill: With NXP100, Nuvectis Pharma Just Staked Its Claim in the New Biotech Gold Rush
TipRanks News
Neutral
Nuvectis Pharma price target raised to $33 from $20 at Roth Capital
TipRanks News
Bullish
Insider Buying: Ron Bentsur Acquires Additional Shares of Nuvectis Pharma Inc (NVCT)
GuruFocus News
Bullish
Nuvectis Pharma Announces Major Public Equity Offering
TipRanks News
Neutral
Closing Bell Movers: AeroVironment jumps after quarterly report
TipRanks News
Bearish

News Score - Last 7 Days

Very Positive
NVCT
Sector Average
Media Buzz
This Week6 articles
Weekly Average0 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NVCT’s Media Buzz Sentiment?
Currently, no data Available
What is NVCT’s weekly average amount of articles?
Currently, no data Available
What is NVCT’s News Sentiment?
100% of articles about NVCT were positive this week, compared to its sector average of 91%.
    Healthcare Stocks that are Trending in the News
    CNCCentene
    GMABGenmab
    LHLabcorp Holdings
    KIDSOrthoPediatrics
    DXCMDexcom
    Showing the stocks with the most bullish news sentiment over the past week